Yan Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Liao has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Yang Jiang
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, PR China
4 shared publicationsMan-Yu Zhou
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102446, China
3 shared publicationsXin Gao
Traditional Chinese Medicine School, Beijing University of Chinese Medicine, Beijing, 102446, China
3 shared publicationsYao Liang
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, PR China
3 shared publicationsBing-Qing Liu
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102446, China
2 shared publicationsJian-Bin Sun
Chongqing Academy of Chinese Materia Medica, Chongqing, 400065, China
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9035
Cordyceps Polysaccharides Attenuate Experimental Ischemic Stroke Injury: Association with IL-17/NF-κB Signaling
Cordyceps polysaccharides (CSP) have shown protective potential in ischemic stroke, but their central inflammatory mechanisms remain unclear. This study examined whether the effects of CSP are associated with interleukin-17 (IL-17)/nuclear factor kappa B (NF-κB)-related signaling. Publicly available human transcriptomic datasets were integrated and analyzed to identify inflammation-related pathways in ischemic stroke, and a public mouse middle cerebral artery occlusion (MCAO) single-cell RNA sequencing (RNA-seq) dataset was analyzed to identify relevant brain cell populations. IL-17 receptor A (IL-17RA) knockdown was performed in oxygen–glucose deprivation (OGD)-exposed SH-SY5Y cells. The effects of CSP were further evaluated in MCAO rats and OGD-exposed BV-2 cells. Bioinformatics analyses showed enrichment of IL-17 and NF-κB signaling in ischemic stroke datasets, and single-cell module-score analysis showed that microglia exhibited the largest MCAO-associated increase in IL-17/NF-κB-related module scores. IL-17RA knockdown improved the viability of OGD-exposed SH-SY5Y cells. In MCAO rats, CSP improved neurological and behavioral outcomes, increased cerebral blood flow, and reduced cerebral edema, infarct volume, neuronal loss, microglial responses, and IL-17A/IL-17RA expression. In OGD-exposed BV-2 cells, CSP reduced IL-17A, IL-17RA, NF-κB activator 1 (ACT1), tumor necrosis factor receptor-associated factor 6 (TRAF6), IL-1β, IL-6, and the phosphorylated p65/total p65 ratio. These findings suggest that the protective effects of CSP in ischemic stroke models are associated with attenuation of IL-17/NF-κB-related neuroinflammation.
- 12 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9035
Open AccessCordyceps Polysaccharides Attenuate Experimental Ischemic Stroke Injury: Association with IL-17/NF-κB Signaling
Cordyceps polysaccharides (CSP) have shown protective potential in ischemic stroke, but their central inflammatory mechanisms remain unclear. This study examined whether the effects of CSP are associated with interleukin-17 (IL-17)/nuclear factor kappa B (NF-κB)-related signaling. Publicly available human transcriptomic datasets were integrated and analyzed to identify inflammation-related pathways in ischemic stroke, and a public mouse middle cerebral artery occlusion (MCAO) single-cell RNA sequencing (RNA-seq) dataset was analyzed to identify relevant brain cell populations. IL-17 receptor A (IL-17RA) knockdown was performed in oxygen–glucose deprivation (OGD)-exposed SH-SY5Y cells. The effects of CSP were further evaluated in MCAO rats and OGD-exposed BV-2 cells. Bioinformatics analyses showed enrichment of IL-17 and NF-κB signaling in ischemic stroke datasets, and single-cell module-score analysis showed that microglia exhibited the largest MCAO-associated increase in IL-17/NF-κB-related module scores. IL-17RA knockdown improved the viability of OGD-exposed SH-SY5Y cells. In MCAO rats, CSP improved neurological and behavioral outcomes, increased cerebral blood flow, and reduced cerebral edema, infarct volume, neuronal loss, microglial responses, and IL-17A/IL-17RA expression. In OGD-exposed BV-2 cells, CSP reduced IL-17A, IL-17RA, NF-κB activator 1 (ACT1), tumor necrosis factor receptor-associated factor 6 (TRAF6), IL-1β, IL-6, and the phosphorylated p65/total p65 ratio. These findings suggest that the protective effects of CSP in ischemic stroke models are associated with attenuation of IL-17/NF-κB-related neuroinflammation.
- 7 April 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 366, 121661
Chen's Jinshui Pills ameliorate diabetic retinopathy in mice and are associated with intestinal barrier protection and anti-inflammatory effects
- 7 April 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 366, 121661
Chen's Jinshui Pills ameliorate diabetic retinopathy in mice and are associated with intestinal barrier protection and anti-inflammatory effects
- 25 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 170
Sagittaria Sagittifolia Polysaccharide Ameliorates Diabetic Retinopathy in Mice via Inhibiting TLR4-Mediated Microglial Activation
Sagittaria sagittifolia polysaccharide (SSP) exhibits anti-inflammatory, antioxidant, lipid-regulating, and hypoglycemic properties, demonstrating therapeutic potential against diabetic retinopathy (DR). This study aimed to investigate the intervention efficacy of SSP in DR mice and its regulatory effects on retinal microglia activation. The type 2 diabetic mouse model was established by high-fat diet feeding combined with streptozotocin (STZ) intravenous injection. At week 9, retinal vascular pathology was assessed via fundus photography and fluorescein angiography. Serum lipid metabolism TG, CHO, LDL, and HDL were quantified using an automated biochemical analyzer. Retinal histopathology and thickness were evaluated through HE staining combined with Evans blue staining. Microglial activation adjacent to retinal vasculature was visualized by immunofluorescence, while retinal apoptosis was examined using immunohistochemistry and TUNEL staining. Co-localization of TLR4 and Iba was analyzed by immunofluorescence. Protein expression levels of TLR4, Myd88, P-p65, and total p65 in retinal tissues were determined by Western blot. SSP treatment significantly attenuated DR progression, as evidenced by preserved retinal vascular integrity, restored retinal thickness, reduced vascular leakage, lowered fasting blood glucose, and regulated lipid metabolism (reduced TG/TC/LDL-C, increased HDL-C). Furthermore, SSP suppressed pathological recruitment of microglia to retinal vasculature and inhibited their pro-inflammatory morphological transition. Mechanistically, SSP downregulated TLR4/Iba co-expression and inhibited the downstream Myd88/NF-κB signaling pathway. The study results demonstrated that SSP can delay the progression of retinopathy in type 2 diabetic mice. This mechanism seems to be associated with SSP’s hypoglycemic and lipid-regulating effects, along with its inhibition of microglia-mediated inflammatory responses.
- 25 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 170
Sagittaria Sagittifolia Polysaccharide Ameliorates Diabetic Retinopathy in Mice via Inhibiting TLR4-Mediated Microglial Activation
Sagittaria sagittifolia polysaccharide (SSP) exhibits anti-inflammatory, antioxidant, lipid-regulating, and hypoglycemic properties, demonstrating therapeutic potential against diabetic retinopathy (DR). This study aimed to investigate the intervention efficacy of SSP in DR mice and its regulatory effects on retinal microglia activation. The type 2 diabetic mouse model was established by high-fat diet feeding combined with streptozotocin (STZ) intravenous injection. At week 9, retinal vascular pathology was assessed via fundus photography and fluorescein angiography. Serum lipid metabolism TG, CHO, LDL, and HDL were quantified using an automated biochemical analyzer. Retinal histopathology and thickness were evaluated through HE staining combined with Evans blue staining. Microglial activation adjacent to retinal vasculature was visualized by immunofluorescence, while retinal apoptosis was examined using immunohistochemistry and TUNEL staining. Co-localization of TLR4 and Iba was analyzed by immunofluorescence. Protein expression levels of TLR4, Myd88, P-p65, and total p65 in retinal tissues were determined by Western blot. SSP treatment significantly attenuated DR progression, as evidenced by preserved retinal vascular integrity, restored retinal thickness, reduced vascular leakage, lowered fasting blood glucose, and regulated lipid metabolism (reduced TG/TC/LDL-C, increased HDL-C). Furthermore, SSP suppressed pathological recruitment of microglia to retinal vasculature and inhibited their pro-inflammatory morphological transition. Mechanistically, SSP downregulated TLR4/Iba co-expression and inhibited the downstream Myd88/NF-κB signaling pathway. The study results demonstrated that SSP can delay the progression of retinopathy in type 2 diabetic mice. This mechanism seems to be associated with SSP’s hypoglycemic and lipid-regulating effects, along with its inhibition of microglia-mediated inflammatory responses.
- 24 November 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 454 (2) , 114841
Sagittaria sagittifolia polysaccharide regulates Nrf2-mediated antioxidant to improve apoptosis and ferroptosis in high glucose-induced lens epithelial cells
- 24 November 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 454 (2) , 114841
Sagittaria sagittifolia polysaccharide regulates Nrf2-mediated antioxidant to improve apoptosis and ferroptosis in high glucose-induced lens epithelial cells
- 10 November 2025
- Published by Springer Nature in Inflammopharmacology
- Vol. 33 (12) , 7329-7345
Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy
The pathogenesis of diabetic retinopathy DR is highly complex, and in recent years, increasing attention has been directed toward the role of the gut in its development. Evidence suggests that intestinal barrier dysfunction is a frequent pathological feature in both DR patients and animal models, facilitating the translocation of gut microbiota and their metabolites into the systemic circulation. On one hand, these translocated microbial components and metabolites activate intestinal immune cells, promoting the migration of gut-derived immune cells to the retina or choroid, thereby contributing to retinal neuroinflammation. On the other hand, they may compromise the integrity of the blood-retina barrier, disrupting the retinal microenvironment. This review explores the influence of the gut on DR pathogenesis through several key mechanisms: alterations in gut microbiota and their metabolites, impairment of intestinal barrier integrity, dysregulated gut immune responses, translocation routes of gut-derived components (including immune cells, microbes, and metabolites) to the retina, and the resulting retinal pathology and microglial-mediated neuroinflammation. By elucidating the pathological mechanisms underlying the gut-retina axis, we aim to identify critical molecular and cellular targets involved in DR progression and to provide new insights for the development of innovative therapeutic strategies.
- 10 November 2025
- Published by Springer Nature in Inflammopharmacology
- Vol. 33 (12) , 7329-7345
Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy
The pathogenesis of diabetic retinopathy DR is highly complex, and in recent years, increasing attention has been directed toward the role of the gut in its development. Evidence suggests that intestinal barrier dysfunction is a frequent pathological feature in both DR patients and animal models, facilitating the translocation of gut microbiota and their metabolites into the systemic circulation. On one hand, these translocated microbial components and metabolites activate intestinal immune cells, promoting the migration of gut-derived immune cells to the retina or choroid, thereby contributing to retinal neuroinflammation. On the other hand, they may compromise the integrity of the blood-retina barrier, disrupting the retinal microenvironment. This review explores the influence of the gut on DR pathogenesis through several key mechanisms: alterations in gut microbiota and their metabolites, impairment of intestinal barrier integrity, dysregulated gut immune responses, translocation routes of gut-derived components (including immune cells, microbes, and metabolites) to the retina, and the resulting retinal pathology and microglial-mediated neuroinflammation. By elucidating the pathological mechanisms underlying the gut-retina axis, we aim to identify critical molecular and cellular targets involved in DR progression and to provide new insights for the development of innovative therapeutic strategies.
- Open Access
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110806
Sagittaria sagittifolia polysaccharide interferes with arachidonic acid metabolism in non-alcoholic fatty liver disease mice via Nrf2/HO-1 signaling pathway
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110806
Open AccessSagittaria sagittifolia polysaccharide interferes with arachidonic acid metabolism in non-alcoholic fatty liver disease mice via Nrf2/HO-1 signaling pathway
- Open Access
Metabolomic Study to Determine the Mechanism Underlying the Effects of Sagittaria sagittifolia Polysaccharide on Isoniazid- and Rifampicin-Induced Hepatotoxicity in Mice
In this study, a non-targeted metabolic profiling method based on ultra-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) was used to characterize the plasma metabolic profile associated with the protective effects of the Sagittaria sagittifolia polysaccharide (SSP) on isoniazid (INH)—and rifampicin (RFP)-induced hepatotoxicity in mice. Fourteen potential biomarkers were identified from the plasma of SSP-treated mice. The protective effects of SSP on hepatotoxicity caused by the combination of INH and RFP (INH/RFP) were further elucidated by investigating the related metabolic pathways. INH/RFP was found to disrupt fatty acid metabolism, the tricarboxylic acid cycle, amino acid metabolism, taurine metabolism, and the ornithine cycle. The results of the metabolomics study showed that SSP provided protective effects against INH/RFP-induced liver injury by partially regulating perturbed metabolic pathways.
Open AccessMetabolomic Study to Determine the Mechanism Underlying the Effects of Sagittaria sagittifolia Polysaccharide on Isoniazid- and Rifampicin-Induced Hepatotoxicity in Mice
In this study, a non-targeted metabolic profiling method based on ultra-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) was used to characterize the plasma metabolic profile associated with the protective effects of the Sagittaria sagittifolia polysaccharide (SSP) on isoniazid (INH)—and rifampicin (RFP)-induced hepatotoxicity in mice. Fourteen potential biomarkers were identified from the plasma of SSP-treated mice. The protective effects of SSP on hepatotoxicity caused by the combination of INH and RFP (INH/RFP) were further elucidated by investigating the related metabolic pathways. INH/RFP was found to disrupt fatty acid metabolism, the tricarboxylic acid cycle, amino acid metabolism, taurine metabolism, and the ornithine cycle. The results of the metabolomics study showed that SSP provided protective effects against INH/RFP-induced liver injury by partially regulating perturbed metabolic pathways.